GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ImmunityBio Inc (FRA:26CA) » Definitions » Other Current Liabilities

ImmunityBio (FRA:26CA) Other Current Liabilities : €11.27 Mil (As of Mar. 2025)


View and export this data going back to 2021. Start your Free Trial

What is ImmunityBio Other Current Liabilities?

ImmunityBio's other current liabilities for the quarter that ended in Mar. 2025 was €11.27 Mil.

ImmunityBio's quarterly other current liabilities declined from Sep. 2024 (€16.31 Mil) to Dec. 2024 (€15.26 Mil) and declined from Dec. 2024 (€15.26 Mil) to Mar. 2025 (€11.27 Mil).

ImmunityBio's annual other current liabilities declined from Dec. 2022 (€18.63 Mil) to Dec. 2023 (€16.79 Mil) and declined from Dec. 2023 (€16.79 Mil) to Dec. 2024 (€15.26 Mil).


ImmunityBio Other Current Liabilities Historical Data

The historical data trend for ImmunityBio's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ImmunityBio Other Current Liabilities Chart

ImmunityBio Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Current Liabilities
Get a 7-Day Free Trial 14.79 14.62 18.63 16.79 15.26

ImmunityBio Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.55 12.58 16.31 15.26 11.27

ImmunityBio Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.


ImmunityBio Other Current Liabilities Related Terms

Thank you for viewing the detailed overview of ImmunityBio's Other Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


ImmunityBio Business Description

Traded in Other Exchanges
Address
3530 John Hopkins Court, San Diego, CA, USA, 92121
ImmunityBio Inc is an integrated clinical-stage biotechnology company discovering, developing, and commercializing next-generation immuno- and cellular therapies that bolster the natural immune system to drive and sustain an immune response. Its platforms for the development of biologic product candidates include (i) antibody-cytokine fusion proteins, (ii) DNA, RNA, and recombinant protein vaccines, and (iii) cell therapies. Its focus includes bladder, lung, and colorectal cancers and GBM and its product candidate Anktiva is an IL-15 superagonist antibody-cytokine fusion protein. It has two geographical segments: the United States and Europe. Key revenue is generated from the United States.

ImmunityBio Headlines

No Headlines